Folks with a suspicious-looking mole or questionable skin lesion often have to endure a scalpel or shaver so their doctor can cut off a sample to send in for biopsy. But a new, noninvasive "virtual ...
Using skin biopsy samples, investigators found that patients with severe COVID-19 had clots in small venous and arterial blood vessels in skin that appears normal. This was not seen in the skin of ...
Your skin is your largest organ, but it doesn’t get the attention it deserves—especially when it comes to skin checks for cancer. That should change, says Dr. Susan Massick, associate professor of ...
Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., Nov. 6, 2025 /PRNewswire/ -- CND Life ...
Assessing pathological synuclein in simple skin biopsies can take the place of more invasive diagnostic procedures. Diagnosing neurodegenerative conditions called synucleinopathies, particularly in ...
A minimally invasive test was able to identify pathology in patients at different stages of disease and potentially enable earlier intervention, researchers report. Using skin biopsy samples, ...
A new 'virtual histology' technology shows promise by analyzing images of suspicious-looking lesions and quickly producing a detailed, microscopic image of the skin, bypassing several standard steps ...
Most skin cancers are curable, especially if medical professionals identify and treat them early. Doctors will usually opt to remove early-stage skin cancer with surgery. Although melanoma only ...
The MarketWatch News Department was not involved in the creation of this content. Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback